Ruan Y - Search Results

1

Circ_103809 Aggravates the Malignant Phenotype of Pancreatic Cancer Through Modulating miR-197-3p/TSPAN3 Axis.

Wu X, Zhou S, Wang L, Ma J, Zhou Y, Ruan Y, Shao H, Zhou X, Li H. Wu X, et al. Among authors: ruan y. Mol Biotechnol. 2024 Sep;66(9):2455-2466. doi: 10.1007/s12033-023-00874-0. Epub 2023 Sep 23. Mol Biotechnol. 2024. PMID: 37740818

2

MEG2 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting AKT pathway.

Ying D, Ruan Y, Zhou X. Ying D, et al. Among authors: ruan y. Gene. 2019 Mar 1;687:1-8. doi: 10.1016/j.gene.2018.11.003. Epub 2018 Nov 3. Gene. 2019. PMID: 30399427

3

LncRNA Gm4419 induces cell apoptosis in hepatic ischemia-reperfusion injury via regulating the miR-455-SOX6 axis.

Ying D, Zhou X, Ruan Y, Wang L, Wu X. Ying D, et al. Among authors: ruan y. Biochem Cell Biol. 2020 Aug;98(4):474-483. doi: 10.1139/bcb-2019-0331. Epub 2020 Feb 29. Biochem Cell Biol. 2020. PMID: 32114773

4

HDAC6 inhibitor, ACY1215 suppress the proliferation and induce apoptosis of gallbladder cancer cells and increased the chemotherapy effect of gemcitabine and oxaliplatin.

Ruan Y, Wang L, Lu Y. Ruan Y, et al. Drug Dev Res. 2021 Jun;82(4):598-604. doi: 10.1002/ddr.21780. Epub 2021 Jan 11. Drug Dev Res. 2021. PMID: 33428788

5

LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis.

Su J, Chen D, Ruan Y, Tian Y, Lv K, Zhou X, Ying D, Lu Y. Su J, et al. Among authors: ruan y. Bioengineered. 2022 Mar;13(3):6978-6995. doi: 10.1080/21655979.2022.2037921. Bioengineered. 2022. PMID: 35311623 Free PMC article.

6

LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2.

Lu Y, Ying D, Tian Y, Ruan Y, Cheng G, Lv K, Zhou X, Han S. Lu Y, et al. Among authors: ruan y. Clinics (Sao Paulo). 2022 Jun 2;77:100047. doi: 10.1016/j.clinsp.2022.100047. eCollection 2022. Clinics (Sao Paulo). 2022. PMID: 35662010 Free PMC article.

7

lncRNA ZFAS1 Promotes HMGCR mRNA Stabilization via Binding U2AF2 to Modulate Pancreatic Carcinoma Lipometabolism.

Wang L, Ruan Y, Wu X, Zhou X. Wang L, et al. Among authors: ruan y. J Immunol Res. 2022 Jul 8;2022:4163198. doi: 10.1155/2022/4163198. eCollection 2022. J Immunol Res. 2022. PMID: 35846429 Free PMC article.

8

CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1.

Lu Y, Zhou S, Cheng G, Ruan Y, Tian Y, Lv K, Han S, Zhou X. Lu Y, et al. Among authors: ruan y. J Oncol. 2022 Aug 24;2022:1911592. doi: 10.1155/2022/1911592. eCollection 2022. J Oncol. 2022. PMID: 36059806 Free PMC article.

9

Literature review of imaging, pathological diagnosis, and outcomes of metachronous lung and pancreatic metastasis of cecal cancer.

Wu X, Zhou S, Zhou X, Xu X, Wang L, Ruan Y, Lu J, Li H, Xu H, Ma X, Li H. Wu X, et al. Among authors: ruan y. World J Surg Oncol. 2022 Oct 17;20(1):341. doi: 10.1186/s12957-022-02797-7. World J Surg Oncol. 2022. PMID: 36253824 Free PMC article. Review.

10

Exosome-transmitted hsa_circ_0012634 suppresses pancreatic ductal adenocarcinoma progression through regulating miR-147b/HIPK2 axis.

Wang L, Wu X, Ruan Y, Zhang X, Zhou X. Wang L, et al. Among authors: ruan y. Cancer Biol Ther. 2023 Dec 31;24(1):2218514. doi: 10.1080/15384047.2023.2218514. Cancer Biol Ther. 2023. PMID: 37326330 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,375 results

Search Page

Filters